THERACLIONTHERACLIONTHERACLION

THERACLION

No trades
See on Supercharts

ALTHE fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Théraclion SA develops, manufactures, and markets oncological medical equipment. Its products are marketed under the brands of Sonovein, EchoPulse and EPack. EchoPulse is a device used for non-invasive and outpatient treatment of fibroadenoma of the breast and thyroid nodules. EPack is a single-use disposable patented system used for cooling and coupling functions. The company was founded by François Lacoste and Jérôme Lebon on August 5, 2004 and is headquartered in Malakoff, France.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
ALTHE has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company